Furlan, Alessandro http://orcid.org/0000-0001-5149-6331
Corona, Alberto http://orcid.org/0000-0002-2258-1905
Boyle, Sara http://orcid.org/0000-0002-1006-7327
Sharma, Radhashree
Rubino, Rachel http://orcid.org/0000-0003-3904-0635
Habel, Jill
Gablenz, Eva Carlotta http://orcid.org/0000-0002-1632-4507
Giovanniello, Jacqueline http://orcid.org/0000-0002-4558-7728
Beyaz, Semir http://orcid.org/0000-0003-4730-4012
Janowitz, Tobias http://orcid.org/0000-0002-7820-3727
Shea, Stephen David http://orcid.org/0000-0001-6927-0189
Funding for this research was provided by:
European Molecular Biology Organization (ALTF 458-2017)
Vetenskapsrådet (2017-00333)
Charles H. Revson Foundation (19-23)
The German Academic Scholarship Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH108924, R01MH101214)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA050374)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS104944)
Article History
Received: 11 September 2021
Accepted: 6 September 2022
First Online: 20 October 2022
Competing interests
: The authors declare no competing interests.